eGain Corp Files 10-Q for Q2 FY25

TL;DR

**eGain 10-Q filed: Q2 FY25 financials out, check for updates.**

AI Summary

eGain Corporation filed its 10-Q for the period ending December 31, 2024. The filing details financial performance and operational updates for the second quarter of fiscal year 2025. Key financial data and disclosures relevant to investors are presented.

Why It Matters

This filing provides investors with a detailed look at eGain's financial health and operational status for the recent quarter, influencing investment decisions.

Risk Assessment

Risk Level: medium — 10-Q filings are standard for public companies, but the specific financial details and disclosures within can reveal varying levels of risk.

Key Numbers

• N/A — Revenue (Specific revenue figures are not directly extracted from this header-level data.)
• N/A — Net Income (Specific net income figures are not directly extracted from this header-level data.)
• N/A — Earnings Per Share (Specific EPS figures are not directly extracted from this header-level data.)

Key Players & Entities

• EGAIN Corp (company) — Filer of the 10-Q
• December 31, 2024 (date) — End of reporting period
• 20250213 (date) — Filing date
• 1252 BORREGAS AVENUE, SUNNYVALE, CA 94089 (address) — Company business and mailing address

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share EGAN The Nasdaq Stock Mar

Filing Documents

• egan-20241231x10q.htm (10-Q) — 2103KB
• egan-20241231xex31d1.htm (EX-31.1) — 15KB
• egan-20241231xex31d2.htm (EX-31.2) — 15KB
• egan-20241231xex32d1.htm (EX-32.1) — 7KB
• egan-20241231xex32d2.htm (EX-32.2) — 7KB
• 0001558370-25-000941.txt ( ) — 6821KB
• egan-20241231.xsd (EX-101.SCH) — 34KB
• egan-20241231_cal.xml (EX-101.CAL) — 49KB
• egan-20241231_def.xml (EX-101.DEF) — 134KB
• egan-20241231_lab.xml (EX-101.LAB) — 356KB
• egan-20241231_pre.xml (EX-101.PRE) — 243KB
• egan-20241231x10q_htm.xml (XML) — 1116KB

Financial Statements (Unaudited)

Financial Statements (Unaudited) 2 Condensed Consolidated Balance Sheets as of December 31, 2024 and June 30, 2024 2 Condensed Consolidated Statements of Operations for the Three and Six Months Ended December 31, 2024 and 2023 3 Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended December 31, 2024 and 2023 4 Condensed Consolidated Statements of Stockholders' Equity for the Three and Six Months Ended December 31, 2024 and 2023 5 Condensed Consolidated Statements of Cash Flows for the Six Months Ended December 31, 2024 and 2023 9 Notes to Condensed Consolidated Financial Statements 10 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 25 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 38 Item 4.

Controls and Procedures

Controls and Procedures 39 PART II. OTHER INFORMATION 40 Item 1.

Legal Proceedings

Legal Proceedings 40 Item 1A.

Risk Factors

Risk Factors 40 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 58 Item 5. Other Information 59 Item 6. Exhibits 60

Signatures

Signatures 61 1 Table of Contents

FINANCIAL INFORMATIO N

PART I. FINANCIAL INFORMATIO N

Financial Statements

Item 1. Financial Statements EGAIN CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except par value data) (unaudited) December 31, June 30, 2024 2024 ASSETS Current assets: Cash and cash equivalents $ 70,531 $ 70,003 Restricted cash 8 8 Accounts receivable, less provision for credit losses of $ 67 and $ 59 as of December 31, 2024 and June 30, 2024, respectively 15,795 31,731 Costs capitalized to obtain revenue contracts, net 1,231 1,272 Prepaid expenses 2,230 2,915 Other current assets 855 1,195 Total current assets 90,650 107,124 Property and equipment, net 515 441 Operating lease right-of-use assets 3,834 3,811 Costs capitalized to obtain revenue contracts, net of current portion 1,645 1,779 Goodwill 13,186 13,186 Other assets, net 1,427 1,511 Total assets $ 111,257 $ 127,852 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 1,838 $ 2,725 Accrued compensation 6,227 7,642 Accrued liabilities 2,771 5,078 Operating lease liabilities 1,089 1,179 Deferred revenue 37,358 45,989 Total current liabilities 49,283 62,613 Deferred revenue, net of current portion 3,008 3,280 Operating lease liabilities, net of current portion 2,790 2,592 Other long-term liabilities 918 871 Total liabilities 55,999 69,356 Commitments and contingencies (Note 6) Stockholders' equity: Common stock, par value $ 0.001 - authorized: 60,000 shares; issued: 33,110 and 32,698 shares; outstanding: 28,481 and 29,160 shares as of December 31, 2024 and June 30, 2024, respectively 33 33 Additional paid-in capital 409,551 407,416 Treasury stock, at cost: 4,629 and 3,538 shares of common stock as of December 31, 2024 and June 30, 2024, respectively ( 30,025 ) ( 23,031 ) Notes receivable from stockholders ( 21 ) ( 21 ) Accumulated other comprehensive loss ( 1,942 ) ( 2,240 ) Accumulated deficit ( 322,338

View Full Filing

View this 10-Q filing on SEC EDGAR